{"DataElement":{"publicId":"6821477","version":"1","preferredName":"AR-V7 mRNA Reverse Transcriptase-Polymerase Chain Reaction Result","preferredDefinition":"Text term that represents the result of the AR-V7 messenger RNA Reverse Transcriptase-Polymerase Chain Reaction  test.","longName":"6821447v1.0:6788014v1.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6821447","version":"1","preferredName":"Androgen Receptor Splice Variant 3 Messenger RNA Reverse Transcriptase-Polymerase Chain Reaction Outcome","preferredDefinition":"Androgen receptor protein that is comprised of the amino acids encoded by exons 1-3 and those encoded by cryptic exon 3 (CE3) of the human AR gene. This variant protein contains nuclear receptor transcriptional activation and DNA binding domains and is missing the hinge region and the nuclear receptor ligand binding and activation function-2 domains. Expression of this variant is associated with both a constitutively active, gain-of-function phenotype and prostate cancer._A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein._A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase._The result of an action.","longName":"6821418v1.0:6821445v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6821418","version":"1","preferredName":"Androgen Receptor Splice Variant 3","preferredDefinition":"Androgen receptor protein that is comprised of the amino acids encoded by exons 1-3 and those encoded by cryptic exon 3 (CE3) of the human AR gene. This variant protein contains nuclear receptor transcriptional activation and DNA binding domains and is missing the hinge region and the nuclear receptor ligand binding and activation function-2 domains. Expression of this variant is associated with both a constitutively active, gain-of-function phenotype and prostate cancer.","longName":"C128292","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Androgen Receptor Splice Variant 3","conceptCode":"C128292","definition":"Androgen receptor protein that is comprised of the amino acids encoded by exons 1-3 and those encoded by cryptic exon 3 (CE3) of the human AR gene. This variant protein contains nuclear receptor transcriptional activation and DNA binding domains and is missing the hinge region and the nuclear receptor ligand binding and activation function-2 domains. Expression of this variant is associated with both a constitutively active, gain-of-function phenotype and prostate cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4DC1B4-4CD7-15BB-E053-F662850AA5B9","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"ONEDATA","dateModified":"2019-07-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6821445","version":"1","preferredName":"Messenger RNA Reverse Transcriptase-Polymerase Chain Reaction Outcome","preferredDefinition":"A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.:A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.:The result of an action.","longName":"C813:C18136:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Messenger RNA","conceptCode":"C813","definition":"A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4DC1B4-4D63-15BB-E053-F662850AA5B9","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"ONEDATA","dateModified":"2019-07-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4DC1B4-4D74-15BB-E053-F662850AA5B9","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeDescription":"Created for Prostate request 7.1.19  mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6788014","version":"1","preferredName":"Reverse Transcriptase Polymerase Chain Reaction Result","preferredDefinition":"The result of an action.","longName":"6788014v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BB783D0-780B-0352-E053-F662850AA414","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"ONEDATA","dateModified":"2019-06-19","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative Finding","ValueMeaning":{"publicId":"2840098","version":"1","preferredName":"Negative Finding","longName":"2840098","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635F3981-C786-F359-E040-BB89AD435EC5","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-20","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BB783D0-7815-0352-E053-F662850AA414","beginDate":"2018-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"ONEDATA","dateModified":"2019-06-19","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive Finding","ValueMeaning":{"publicId":"5042698","version":"1","preferredName":"Positive Finding","longName":"5042698","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23BCDB4E-8EE7-8E8D-E050-BB89AD432DF3","latestVersionIndicator":"Yes","beginDate":"2015-11-04","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-11-04","modifiedBy":"KUMMEROA","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BB783D0-781F-0352-E053-F662850AA414","beginDate":"2018-02-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"ONEDATA","dateModified":"2019-06-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB783D0-77F3-0352-E053-F662850AA414","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeDescription":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000016","version":"1","longName":"Prostate","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"AR-V7 mRNA RT-PCR result","type":"Preferred Question Text","description":"AR-V7 mRNA RT-PCR result","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E4BD309-BDD7-46F0-E053-F662850AAEB0","latestVersionIndicator":"Yes","beginDate":"2019-07-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-23","modifiedBy":"COOPERM","dateModified":"2019-08-19","changeDescription":"Created for prostate request 7.1.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}